BackPhaseRx Overview

PhaseRx Receivables

PhaseRx's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average / median

Loading

PhaseRx Receivables History

Loading

PhaseRx vs. peers: Receivables Comparison

Loading

PhaseRx Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

PhaseRx (PZRXQ) FAQ

PhaseRx (PZRXQ) currently reports a receivables of $0 as of September 2017. In the prior-year period, the figure was $0. Use the charts on this page to explore PhaseRx's receivables history and peer comparisons.

PhaseRx's receivables changed from $0 to $0 (period ending September 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PhaseRx reported $0 in receivables as of September 2017. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PhaseRx, and consider following PZRXQ for alerts when major investors trade the stock.

PhaseRx is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PZRXQ with unrelated industries.